![Jan N. Lessem](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jan N. Lessem
Technik-/Wissenschafts-/F&E-Leiter bei Orthocon, Inc.
Aktive Positionen von Jan N. Lessem
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Orthocon, Inc.
![]() Orthocon, Inc. Medical SpecialtiesHealth Technology Orthocon, Inc. designs, develops, and markets medical implantable devices. It provides implantable products designed to stop bone bleeding. The company was founded in 2005 and is headquartered in Irvington, NY. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 | - |
Karriereverlauf von Jan N. Lessem
Ehemalige bekannte Positionen von Jan N. Lessem
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CombinatoRx, Inc.
![]() CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2003 | 31.01.2007 |
OraPharma, Inc.
![]() OraPharma, Inc. Pharmaceuticals: MajorHealth Technology OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 | 01.01.2003 |
MERCK & CO., INC. | Corporate Officer/Principal | - | 28.02.2011 |
Takeda America Research & Development Center, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Shire Regenerative Medicine, Inc.
![]() Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2008 | - |
Ausbildung von Jan N. Lessem
University of Lund | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Schweden | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 5 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
OraPharma, Inc.
![]() OraPharma, Inc. Pharmaceuticals: MajorHealth Technology OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA. | Health Technology |
Shire Regenerative Medicine, Inc.
![]() Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT. | Health Technology |
CombinatoRx, Inc.
![]() CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | Health Technology |
Orthocon, Inc.
![]() Orthocon, Inc. Medical SpecialtiesHealth Technology Orthocon, Inc. designs, develops, and markets medical implantable devices. It provides implantable products designed to stop bone bleeding. The company was founded in 2005 and is headquartered in Irvington, NY. | Health Technology |
Takeda America Research & Development Center, Inc. |
- Börse
- Insiders
- Jan N. Lessem
- Erfahrung